The report presents a detailed analysis of the Legionella diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Legionella definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:

– Hospitals
– Commercial/Private Labs
– Physician Offices
– Public Health Labs

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Legionella tests.
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Table of Contents

I. Introduction
II. LEGIONELLA Worldwide Market and Technology Overview
A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. France: Test Volume and Diagnostics Sales Forecast By Market Segment
IV. Germany: Market Size, Growth and Major Suppliers' Sales and Market Shares
V. Italy: Test Volume and Diagnostics Sales Forecast By Market Segment
VI. Japan: Market Size, Growth and Major Suppliers' Sales and Market Shares
VII. Spain: Test Volume and Diagnostics Sales Forecast By Market Segment
VIII. UK: Test Volume and Diagnostics Sales Forecast By Market Segment
IX. USA: Market Size, Growth and Major Suppliers' Sales and Market Shares
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako

List of Tables

Major Companies Developing or Marketing Legionella Tests
France Legionella Test Volume and Diagnostics Sales Forecast By Market Segment
Germany Legionella Test Volume and Diagnostics Sales Forecast By Market Segment
Germany Legionella Testing Market Diagnostics Sales By Major Supplier
Italy Legionella Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Legionella Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Legionella Testing Market Diagnostics Sales Forecast By Major Supplier
Spain Legionella Test Volume and Diagnostics Sales Forecast By Market Segment
U.K. Legionella Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Legionella Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Legionella Testing Market Diagnostics Sales By Major Supplier